“…35 Clinically, skeletal limb muscles, which are highly dependent on ATP are frequent targets of myopathy. 36 Previous studies of incidence of myopathy during clevudine treatment have reported various results of 2.9% to 14.6%. 24,26,32,37 In our study, 10 patients developed muscle-related symptoms at 69.7±16.6 weeks, which comprise 11.6%, only in those who were treated with clevudine.…”